(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 4.59% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.71%.
Tilray Brands's revenue in 2025 is $830,766,000.On average, 4 Wall Street analysts forecast TLRY's revenue for 2026 to be $985,233,827,743, with the lowest TLRY revenue forecast at $965,325,463,810, and the highest TLRY revenue forecast at $1,020,334,530,313. On average, 2 Wall Street analysts forecast TLRY's revenue for 2027 to be $1,028,581,960,267, with the lowest TLRY revenue forecast at $1,012,036,571,516, and the highest TLRY revenue forecast at $1,045,127,349,018.
In 2028, TLRY is forecast to generate $1,065,035,712,951 in revenue, with the lowest revenue forecast at $1,065,035,712,951 and the highest revenue forecast at $1,065,035,712,951.